The Regulatory Week in Review: May 29, 2015
- Cephalon, Inc. settled with the Federal Trade Commission (FTC) for allegedly reducing competition by preventing the sale of generic versions of the sleep-disorder drug, Provigil.
- U.S. Senators Debbie Stabenow and Gary Peters introduced the Microbeads Free Waters Act of 2015, legislation geared towards protecting the Great Lakes by phasing out microbeads used in body washes and soaps, which they say has built up as plastic pollution in these waters.
- The U.S. Food and Drug Administration (FDA) released a final rule with new requirements that apply to blood donations including about the medical history obtained before donation and the tests used on donated blood.